BostonPremier Wealth’s Citius Pharmaceuticals CTXR Stock Holding History

BostonPremier Wealth’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9K	Buy	+28,000	New	+$19K	0.01%	79

Other funds holding CTXR

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

Asset Advisory Group Kinnelon, New Jersey $229M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Smallwood Wealth Investment Management Red Bank, New Jersey $229M AUM 23.56% 1-Year Est. Return

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

BostonPremier Wealth's CTXR Position: Q2 2026 in Review

BostonPremier Wealth opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 28,000 shares worth $16.9K. The stake represents 0.01% of the portfolio and ranks #79 among its holdings.

9 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

BostonPremier Wealth held 28,000 shares of Citius Pharmaceuticals worth $16.9K as of Q2 2026.
Citius Pharmaceuticals was a new BostonPremier Wealth position in Q2 2026.
Citius Pharmaceuticals made up 0.01% of BostonPremier Wealth's portfolio in Q2 2026, its #79 holding.
9 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on BostonPremier Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.